The Innovative Medicines Fund - good news for patients but has an opportunity been missed to be more ambitious?

27 June 2022 - NHS England and Improvement has announced the launch of the Innovative Medicines Fund. The ABPI’s Director ...

Read more →

Savara awarded innovation passport in United Kingdom for molgramostim nebuliser solution, a novel investigational inhaled biologic

16 June 2022 - Innovation passport awarded to molgramostim for the treatment of auto-immune pulmonary alveolar proteinosis, a rare lung disease. ...

Read more →

Shionogi signs agreement with NHS England to begin an innovative subscription payment model for reimbursement of its antibiotic, Fetcroja (cefiderocol)

15 June 2022 - Shionogi recognises the UK’s leadership role in introducing the world’s first fully ‘delinked’ pilot reimbursement model; pull ...

Read more →

England’s Innovative Medicines Fund hits another milestone

15 June 2022 - Just like the Cancer Drugs Fund, the time-limited fund for the most promising cancer drugs introduced ...

Read more →

Trends in prescription drug launch prices (2008-2021)

7 June 2022 - Prescription drug spending in the US exceeded half a trillion dollars in 2020. ...

Read more →

The Center for Medicare and Medicaid Innovation - toward value based care

9 May 2022 - Before the enactment of the Patient Protection and Affordable Care Act in 2010, experimentation with Medicare or ...

Read more →

Supporting innovation in Medicaid policy - interventions to increase adoption of RCTs

7 May 2022 - Randomised, controlled trials remain underutilised within the Medicaid program, even though state Medicaid programs regularly implement new ...

Read more →

Are high cost prescription drugs the price of innovation? Disclose the costs of clinical trials.

21 April 2022 - With 40% of Americans struggling to afford prescription medicines and many rationing or delaying initiation of lifesaving ...

Read more →

Nurix Therapeutics awarded Innovation Passport for entry into Innovative Licensing and Access Pathway in the United Kingdom for NX-1607

29 March 2022 - NX-1607 is being evaluated in multiple immuno-oncology indications, including a range of solid tumour types. ...

Read more →

PRIME enables earlier availability of life-changing medicines

3 March 2022 - EMA’s PRIority Medicines (PRIME) scheme has had a positive impact on the authorisation of new medicines that ...

Read more →

How digital therapeutics platforms are revolutionising health care delivery

17 February 2022 - With enormous advances in digital health innovation, we are quickly moving into an age where software platforms ...

Read more →

MTAA welcomes patent box legislation

11 February 2022 - MTAA has welcomed the introduction of the Government’s Patent Box Bill into the House of Representatives ...

Read more →

Patent box legislation to promote Australian innovation

11 February 2022 - Medicines Australia notes the introduction of patent box legislation, Treasury Laws Amendment (Tax Concession for Australian ...

Read more →

Theragnostics announces that its radiotherapeutic for treatment of glioblastoma multiforme has been awarded UK's MHRA innovation passport

10 February 2022 - Promising non-clinical results support Phase 1 clinical study in recurrent glioblastoma multiforme. ...

Read more →

Don’t destroy future drug development

8 December 2021 - With support faltering for the massive big-government blowout Congress is trying to jam through by Christmas, ...

Read more →